Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.

Comaschi M, Corsi A, Di Pietro C, Bellatreccia A, Mariz S; COM06 Study Investigators.

Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):373-9. Epub 2007 Oct 24.

PMID:
17919894
2.

Effects of pioglitazone on lipid and lipoprotein metabolism.

Betteridge DJ.

Diabetes Obes Metab. 2007 Sep;9(5):640-7. Review.

PMID:
17697057
3.

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.

Wulffelé MG, Kooy A, de Zeeuw D, Stehouwer CD, Gansevoort RT.

J Intern Med. 2004 Jul;256(1):1-14. Review.

4.

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus.

Chilcott J, Tappenden P, Jones ML, Wight JP.

Clin Ther. 2001 Nov;23(11):1792-823; discussion 1791. Review.

PMID:
11768834
5.

Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a german statutory healthcare perspective.

Neeser K, Lübben G, Siebert U, Schramm W.

Pharmacoeconomics. 2004;22(5):321-41. Review.

PMID:
15061682
6.
7.

The role of pioglitazone in modifying the atherogenic lipoprotein profile.

Hanefeld M.

Diabetes Obes Metab. 2009 Aug;11(8):742-56. doi: 10.1111/j.1463-1326.2009.01048.x. Epub 2009 Jun 10. Review.

PMID:
19519869
8.

Thiazolidinedione derivatives in type 2 diabetes mellitus.

Tack CJ, Smits P.

Neth J Med. 2006 Jun;64(6):166-74. Review.

9.

Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.

Strowig SM, Raskin P.

Diabetes Obes Metab. 2005 Nov;7(6):633-41. Review.

PMID:
16219007
10.

Long-term glycaemic control with pioglitazone in patients with type 2 diabetes.

Campbell IW.

Int J Clin Pract. 2004 Feb;58(2):192-200. Review. Erratum in: Int J Clin Pract. 2004 Oct;58(10):993.

PMID:
15055868
11.
12.

Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.

Diamant M, Heine RJ.

Drugs. 2003;63(13):1373-405. Review.

PMID:
12825962
13.

Pioglitazone: a review of its use in type 2 diabetes mellitus.

Waugh J, Keating GM, Plosker GL, Easthope S, Robinson DM.

Drugs. 2006;66(1):85-109. Review. Erratum in: Drugs. 2006;66(3):340-1.

PMID:
16398569
14.
15.

Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.

Dailey GE.

Expert Opin Pharmacother. 2003 Aug;4(8):1417-30. Review.

PMID:
12877648
16.

Pharmacokinetics and clinical efficacy of pioglitazone.

Hanefeld M.

Int J Clin Pract Suppl. 2001 Sep;(121):19-25. Review.

PMID:
11594240
17.

The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.

Buse JB, Tan MH, Prince MJ, Erickson PP.

Diabetes Obes Metab. 2004 Mar;6(2):133-56. Review.

PMID:
14746579
18.
19.

[Should the occurrence of a first coronary event change the management of diabetes?].

Timsit J, Dubois-Laforgue D.

Arch Mal Coeur Vaiss. 2000 Dec;93 Spec No 4:39-44. Review. French.

PMID:
11296461
20.

Supplemental Content

Support Center